Li Auto Shares Fall Sharply After U.S. Investment Bank Trims Target Price
By Tracy Qu
Li Auto shares fell sharply in Hong Kong trading after a leading U.S. investment bank cut its target price on the stock and lowered its sales estimates.
Shares of the Chinese electric-vehicle maker, which is also listed in the U.S., fell as much as 9.85% to 125.30 Hong Kong dollars (US$16.02) on Tuesday. Li Auto's American depositary receipts slid 12% overnight.
BofA Securities cut its target price on Li Auto's ADRs to $55 from $60 while maintaining a buy rating on the stock. BofA also lowered its sales volume estimates for Li Auto by 6% and 4%, respectively, for 2024 and 2025, due to softer-than-expected orders for the company's new MEGA car model.
MEGA, Li Auto's first fully electric model, was launched at a price tag of 559,800 yuan (US$77,769) earlier this month.
Nomura auto analyst Joel Ying said Li Auto's share-price drop was mainly related to a brokerage cutting its target price on the stock in the U.S., referring to BofA's move.
Ke Qu, an auto-sector analyst at CCB International Securities, said the share-price decline was triggered by lower-than-expected new orders for the MEGA [multipurpose vehicle]. Qu noted a Chinese media report saying that Li Auto only had 4,000 nonrefundable MEGA orders in the first 15 days of the model's launch.
Nomura's Ying said the market might be overreacting to news regarding the MEGA model, given that the model's sales is unlikely to contribute much to Li Auto's overall full-year shipment target.
The L series extended range EVs still make up the majority of the carmaker's 2024 shipment targets, Ying said.
"If Li Auto can maintain a solid momentum on L series, [for example,] if they can achieve close to 50,000 sales in March 2024, I am expecting positive feedback from the market," Ying said.
Write to Tracy Qu at tracy.qu@wsj.com
(END) Dow Jones Newswires
March 19, 2024 02:33 ET (06:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth